Ratings by Jefferies (Brian Mills)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/5/2021 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2021 | Kadmon Holdings | KDMN | Downgrade | Hold (Buy) |
5.30 (9.50) |
79.25% | Details | |
| 8/9/2021 | Kala Pharmaceuticals | KALA | Maintain | Hold (N/A) |
|
Details | ||
| 7/28/2021 | Karuna Therapeutics Inc. | KRTX | New Coverage | Buy (N/A) |
111.88 (329.83) |
194.81% | Details | |
| 7/22/2021 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2021 | Kadmon Holdings | KDMN | Maintain | Buy (N/A) |
|
Details |
